SCHEMBL4151785

SCHEMBL4151785

COc1ccc(CNc2cncc(-c3ccc(O)cc3)c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.50
HDAC1 Q13547 1/20 0.50
ESR2 Q92731 1/20 0.49
MAPT P10636 4/20 0.47
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
LMNA P02545 1/20 0.47
FYN P06241 2/20 0.47
XDH P47989 1/20 0.46
SLC22A12 Q96S37 1/20 0.46
KCNH2 Q12809 1/20 0.46
CYP11B1 P15538 1/20 0.46
CYP11B2 P19099 1/20 0.46
GAA P10253 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
ALPL P05186 1/20 0.46
CLK1 P49759 1/20 0.45
DYRK1A Q13627 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4148712 0.87 ALPL (0.51) KDM1AHDAC1MAPTNPC1RAB9A
SCHEMBL4155473 0.85 ALDH1A1 (0.51) MAPTRAB9AL3MBTL1LMNAFYN
SCHEMBL4160467 0.83 FYN (0.48) HDAC1MAPTL3MBTL1FYNXDH
SCHEMBL4156602 0.81 FYN (0.51) MAPTRAB9AL3MBTL1FYNXDH
SCHEMBL4149226 0.80 INSR (0.49) ESR2MAPTRAB9AL3MBTL1LMNA
SCHEMBL22191159 0.79 KDM4E (0.47) KDM1AHDAC1MAPTNPC1RAB9A
SCHEMBL5863587 0.79 MAPT (0.70) MAPTNPC1RAB9AL3MBTL1LMNA
SCHEMBL28846873 0.79 MAPT (0.70) MAPTNPC1RAB9AL3MBTL1LMNA
SCHEMBL4140694 0.78 FYN (0.46) MAPTRAB9AL3MBTL1LMNAFYN
SCHEMBL4196517 0.78 DYRK1A (0.54) MAPTFYNKCNH2CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090163515-A1 Compounds Which Bind to the Active Site of Protein Kinase Enzymes BIOFOCUS DISCOVERY LTD. 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163515-A1 Compounds Which Bind to the Active Site of Protein Kinase Enzymes ROCK1, ROCK2, CIT KDM1A 2406/4885HDAC1 2655/4885ESR2 918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.